Parkwood LLC’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-11,702
| Closed | -$884K | – | 116 |
|
2024
Q2 | $884K | Sell |
11,702
-1,853
| -14% | -$140K | 0.11% | 95 |
|
2024
Q1 | $926K | Sell |
13,555
-1,925
| -12% | -$132K | 0.08% | 140 |
|
2023
Q4 | $972K | Sell |
15,480
-1,161
| -7% | -$72.9K | 0.12% | 87 |
|
2023
Q3 | $848K | Buy |
16,641
+1,863
| +13% | +$94.9K | 0.09% | 88 |
|
2023
Q2 | $738K | Sell |
14,778
-2,177
| -13% | -$109K | 0.13% | 94 |
|
2023
Q1 | $635K | Buy |
16,955
+9,637
| +132% | +$361K | 0.09% | 104 |
|
2022
Q4 | $351K | Sell |
7,318
-4,940
| -40% | -$237K | 0.05% | 120 |
|
2022
Q3 | $294K | Buy |
12,258
+348
| +3% | +$8.35K | 0.04% | 125 |
|
2022
Q2 | $259K | Buy |
+11,910
| New | +$259K | 0.05% | 124 |
|
2021
Q1 | – | Sell |
-28,191
| Closed | -$749K | – | 128 |
|
2020
Q4 | $749K | Buy |
+28,191
| New | +$749K | 0.09% | 91 |
|